Page last updated: 2024-09-03

l 368899 and sulpiride

l 368899 has been researched along with sulpiride in 1 studies

Compound Research Comparison

Studies
(l 368899)
Trials
(l 368899)
Recent Studies (post-2010)
(l 368899)
Studies
(sulpiride)
Trials
(sulpiride)
Recent Studies (post-2010) (sulpiride)
460304,152427635

Protein Interaction Comparison

ProteinTaxonomyl 368899 (IC50)sulpiride (IC50)
Carbonic anhydrase 1Homo sapiens (human)1.2
Carbonic anhydrase 2Homo sapiens (human)0.04
Alpha-2A adrenergic receptorHomo sapiens (human)2.019
D(2) dopamine receptorHomo sapiens (human)0.0858
D(3) dopamine receptorHomo sapiens (human)0.2651
D(2) dopamine receptorRattus norvegicus (Norway rat)0.2215
Carbonic anhydrase 4Bos taurus (cattle)0.62
D(2) dopamine receptorCanis lupus familiaris (dog)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumei, S; Nozu, T; Ohhira, M; Okumura, T1

Other Studies

1 other study(ies) available for l 368899 and sulpiride

ArticleYear
Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats.
    Physiology & behavior, 2019, 01-01, Volume: 198

    Topics: Adenosine A1 Receptor Antagonists; Analgesics; Animals; Camphanes; Cannabinoid Receptor Agonists; Dopamine D2 Receptor Antagonists; Hormone Antagonists; Indoles; Male; Naloxone; Narcotic Antagonists; Nociception; Oxytocin; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Reflex; Sulpiride; Xanthines

2019